₨ Official source-observed price
PKR 563.10
1x5's
PKR 112.62 / capsule
✓ Official DRAP price source observed · Source checked 2026-09-22
Price Intelligence
Equivalent price position
Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →
This brandPKR 112.62/ capsule
Price positionNear medianvs like-for-like peer median
Peer comparators158current-price listings
🔒
MedInfoBase Pharma Pro
View Price Intelligence PRO
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Rank & percentilePeer medianFull competitor listPortfolio intelligence
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Cefixime
- Therapeutic area
- Anti-infectives
- Drug class
- Third-generation cephalosporins
- ATC
- J01DD
- Strength
- 400 mg
- Dosage form
- Capsule
- Pack
- 1x5's
- Registration no.
- 034336
- Price record verified
- 2026-08-24
- Latest DRAP source check
- 2026-09-22 05:32
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Traceability
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 563.10 | 2026-08-17 | 2026-08-24 | DRAP PharmaPrice Index | Current |
| PKR 536.59 | 2025-11-05 | 2026-08-08 | DRAP PharmaPrice Index | Historical |
Same generic
Other listed brands
3-Sporin 100 mg/5 mLWerrick Pharmaceuticals · PKR 421.023-Sporin 400 mgWerrick Pharmaceuticals · PKR 563.103-Sporin 100 mg/5 mLWerrick Pharmaceuticals · PKR 221.59Aerocef 100 mg/5 mLRaazee Therapeutics (Pvt Ltd. · PKR 647.57Aerocef 400 mgRaazee Therapeutics (Pvt Ltd. · PKR 592.04Aerocef 100 mg/5 mLRaazee Therapeutics (Pvt Ltd. · PKR 330.39Aerocef DS 200 mg/5 mLRaazee Therapeutics (Pvt Ltd. · PKR 404.32Aksoxime 100 mg/5 mLAkson Pharmaceuticals (Pvt) Ltd · PKR 314.24
Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.
Cite this record
Medicine record · DRAP registration 034336MedInfoBase. (2026). C-Span 400 mg Capsule (1x5's), Mega Pharmaceuticals limited — registration and price record [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/brand/c-span-400-mg-034336-10x5s-mega-pharmaceuticals-limited/ Data observed 24 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 034336.
MedInfoBase. C-Span 400 mg Capsule (1x5's), Mega Pharmaceuticals limited — registration and price record [Internet]. Islamabad: MedInfoBase; 2026 [cited 2026 Sep 23]. Available from: https://medinfobase.com/brand/c-span-400-mg-034336-10x5s-mega-pharmaceuticals-limited/ Data observed 24 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 034336.
MedInfoBase (2026) C-Span 400 mg Capsule (1x5's), Mega Pharmaceuticals limited — registration and price record. Available at: https://medinfobase.com/brand/c-span-400-mg-034336-10x5s-mega-pharmaceuticals-limited/ (Accessed: 23 September 2026).
"C-Span 400 mg Capsule (1x5's), Mega Pharmaceuticals limited — registration and price record." MedInfoBase, 2026, https://medinfobase.com/brand/c-span-400-mg-034336-10x5s-mega-pharmaceuticals-limited/. Accessed 23 Sep 2026.
MedInfoBase. 2026. "C-Span 400 mg Capsule (1x5's), Mega Pharmaceuticals limited — registration and price record." Accessed September 23, 2026. https://medinfobase.com/brand/c-span-400-mg-034336-10x5s-mega-pharmaceuticals-limited/.
Price and registration data on this page were observed on 24 August 2026. Records change over time, so please cite the observation date alongside the access date.